Valuation: Biogen Inc.

Market Cap 3.09TCr 2.69TCr 2.49TCr 2.3TCr 4.33TCr 2,95100Cr 4.41TCr 30TCr 12TCr 1,46600Cr 12TCr 11TCr 4,92900Cr P/E 2026 *
31.6x
P/E 2027 * 17.4x
Enterprise Value 3.62TCr 3.14TCr 2.92TCr 2.69TCr 5.07TCr 3,45200Cr 5.16TCr 35TCr 14TCr 1,71500Cr 14TCr 13TCr 5,76600Cr EV / Sales 2026 *
3.48x
EV / Sales 2027 * 3.13x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-5.62%
1 week-0.37%
Current month+7.51%
1 month-6.29%
3 months+11.34%
6 months+19.46%
Current year+18.79%
1 week 172.36
Extreme 172.36
189.72
1 month 165.54
Extreme 165.54
193
Current year 134.7
Extreme 134.7
193
1 year 108.8
Extreme 108.8
193
3 years 99
Extreme 99
255.4
5 years 99
Extreme 99
317.45
10 years 99
Extreme 99
351.7
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-6.11%-0.37% - - 3.09TCr
+1.57%+8.50%+27.54%-4.66% 7.08TCr
-13.51%-10.70%+17.04%+169.50% 5.44TCr
+3.25%+52.70%+52.70%+52.70% 4.72TCr
-0.11%+8.47%-52.97%-52.04% 4.25TCr
-3.92%+4.74%+57.60%+91.81% 2.58TCr
+4.07%-0.65%+76.21%-51.85% 2.16TCr
-1.78%-4.50%-11.86%+140.71% 1.99TCr
-2.60%-1.81%+78.49%+132.58% 1.63TCr
-0.13%+3.10%+69.03%+129.42% 1.69TCr
Average -1.88%+2.57%+34.86%+67.57% 3.5TCr
Weighted average by Cap. -2.14%+3.68%+26.82%+55.68%

Financials

2026 *2027 *
Net sales 1.04TCr 901.6Cr 837.25Cr 772.14Cr 1.45TCr 99TCr 1.48TCr 9.91TCr 3.88TCr 49TCr 3.9TCr 3.81TCr 1,65500Cr 1.05TCr 915.63Cr 850.28Cr 784.16Cr 1.48TCr 1,00600Cr 1.5TCr 10TCr 3.94TCr 50TCr 3.96TCr 3.87TCr 1,68100Cr
Net income 103.57Cr 90Cr 84Cr 77Cr 145.12Cr 9.89TCr 147.75Cr 988.99Cr 387.23Cr 4.91TCr 388.93Cr 380.41Cr 17TCr 197.43Cr 171.48Cr 159.24Cr 146.86Cr 276.64Cr 19TCr 281.65Cr 1.89TCr 738.16Cr 9.36TCr 741.4Cr 725.17Cr 31TCr
Net Debt 524.8Cr 455.84Cr 423.3Cr 390.38Cr 735.35Cr 50TCr 748.67Cr 5.01TCr 1.96TCr 25TCr 1.97TCr 1.93TCr 84TCr 203.51Cr 176.77Cr 164.15Cr 151.39Cr 285.16Cr 19TCr 290.33Cr 1.94TCr 760.9Cr 9.65TCr 764.24Cr 747.51Cr 32TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
30/26/30 178.12 -6.11% 154
29/26/29 €189.72 +6.66% 390
28/26/28 €177.88 -0.33% 0
27/26/27 €178.46 +0.35% 31
24/26/24 €177.84 -0.53% 31
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
209.23USD
Average target price
232.93USD
Spread / Average Target
+11.33%

Quarterly revenue - Rate of surprise